M/21/074 – Pelican Bidco/Cruinn Diagnostics

Transaction details

The proposed acquisition of sole control by Pelican Bidco Limited of Cruinn Diagnostics Limited has been cleared by the Competition and Consumer Protection Commission.

Notification date Decision date
Tuesday December 14, 2021 Thursday, December 30, 2021
Parties Involved Business activities
Pelican Bidco Limited

Pelican Bidco Limited is a private limited company incorporated in Ireland, and established for the purposes of the Proposed Transaction. It is controlled by funds managed by MML Growth Capital Partners Ireland II Limited. These funds are private equity funds, providing growth capital to private businesses on the island of Ireland for expansion, acquisitions, recapitalisations and shareholder reorganisations.

Cruinn Diagnostics Limited

Cruinn is a distributor and supplier of laboratory diagnostic instruments and consumables to customers in the medical, pharmaceutical, independent laboratory and university spaces. Cruinn also undertakes associated services such as maintenance, calibration and some limited laboratory testing. Cruinn is active in the biochemistry, microbiology, haematology and histopathology segments of the market. Cruinn operates from its base in Dublin.

Economic sector Media merger
Healthcare No
Submissions from third parties due by:
Phase 1 Phase 2
Wednesday, December 29, 2021
Current status: Completed
Cleared (Phase 1)
Authorised Officer Assigned Contact Details
Tiernan Shaw

tiernanshaw@ccpc.ie

Cathal Hanley

cathalhanley@ccpc.ie

Media enquiries: communications@ccpc.ie

Return to Merger Notifications

Join our mailing list

Sign up to receive the latest information about mergers:



Read our privacy statement

Haven’t found what you’re looking for?